Market Overview

St. Jude Wins CE Mark Approval for ViewFlex Xtra ICE Catheter

Related STJ
UPDATE: St. Jude Medical Resolves FDA Warning
Markets Up As Russia Seeks To End Military Activity Near Ukraine

St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today announced European CE Mark approval of its ViewFlex^™ Xtra Intracardiac Echocardiography (ICE) Catheter. Designed for control and maneuverability during complex cardiac ablation procedures, the technology will be on display at the eighteenth annual Boston AF Symposium.

Offering a four-way directional tip, the ViewFlex Xtra ICE Catheter also has the added benefit of auto-lock steering, which allows for single-handed operation of the catheter to minimize repositioning. Paired with the ViewMate^™ Z Intracardiac Ultrasound Console, the integrated products help clinicians better visualize, in real-time, a patient's cardiac anatomy, including internal structure of the heart and blood flow direction. The high-resolution images and vivid color displays provide improved guidance for physicians.

Posted-In: News FDA

 

Related Articles (STJ)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters